文献速递糖尿病肥胖与代谢综合征

NT-proBNP与糖尿病风险及糖尿病相关并发症风险呈相反关联

Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications.
PubMed 文献 · Diabetes Care · 2020-08-17

在欧洲癌症与营养前瞻性调查(EPIC)-波茨坦队列的病例-队列研究中,基线血浆NT-proBNP每翻倍与2型糖尿病风险呈线性负相关(HR 0.91,95%CI 0.86–0.98),该关联仅见于女性;在发生糖尿病者中,NT-proBNP与糖尿病并发症风险呈正相关(总体HR 1.31,95%CI 1.13–1.53)。作者认为NT-proBNP或有助于监测糖尿病相关微血管和大血管并发症风险,需在未来前瞻性研究中进一步探讨。

要点

  • NT-proBNP每翻倍与2型糖尿病风险呈负相关(HR 0.91,95%CI 0.86–0.98),仅见于女性。
  • 在发生糖尿病者中,NT-proBNP与糖尿病并发症风险呈正相关(总体HR 1.31,95%CI 1.13–1.53)。
  • 作者认为NT-proBNP或有助于监测糖尿病相关微血管和大血管并发症风险。

核心结论

  • 较高的NT-proBNP水平与较低的糖尿病风险相关,但在发生糖尿病者中NT-proBNP是血管并发症的生物标志物,且独立于潜在混杂因素。
  • 作者认为NT-proBNP或有助于监测糖尿病相关微血管和大血管并发症风险,需在未来前瞻性研究中进一步探讨。

研究设计与样本

  • 在欧洲癌症与营养前瞻性调查(EPIC)-波茨坦队列内进行的病例-队列研究。
  • 包括随机子队列(n=1,294)、2型糖尿病 incident 病例(n=649)和心血管疾病 incident 病例(n=478)。
  • 对2型糖尿病 incident 病例(n=545)随访微血管并发症(n=133)和大血管并发症(n=50)。
  • 在基线时对初始健康参与者测量血浆NT-proBNP。

主要发现

  • 在多变量模型中,NT-proBNP每翻倍与2型糖尿病 incident 风险呈线性负相关,HR(95%CI)为0.91(0.86,0.98)。
  • 该关联仅见于女性(HR 0.80 [95%CI 0.72,0.90]),男性为0.98(95%CI 0.91,1.07)。
  • 在发生糖尿病者中,NT-proBNP与糖尿病并发症呈正相关:总体HR 1.31(95%CI 1.13,1.53)。
  • 微血管并发症HR 1.20(95%CI 1.01,1.43)。
  • 大血管并发症HR 1.37(95%CI 1.03,1.83)。

临床怎么用

  • 作者认为NT-proBNP或有助于监测糖尿病相关微血管和大血管并发症风险。
  • 作者提出该用途需在未来前瞻性研究中进一步探讨。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) is a classic diagnostic and prognostic marker for heart failure. However, it is inversely associated with diabetes risk. We aimed to investigate relationships of NT-proBNP with risk of diabetes-related complications in initially healthy individuals. RESEARCH DESIGN AND METHODS: We performed a case-cohort study within the European Prospective Investigation Into Cancer and Nutrition (EPIC)-Potsdam cohort including a random subcohort (n = 1,294) and incident cases of type 2 diabetes (n = 649) and cardiovascular diseases (n = 478). Incident cases of type 2 diabetes (n = 545) were followed up for microvascular (n = 133) and macrovascular (n = 50) complications. Plasma NT-proBNP was measured at baseline in initially healthy participants. RESULTS: In multivariable models, NT-proBNP was linearly inversely associated with incident type 2 diabetes with a hazard ratio (HR) (95% CI) per doubling in NT-proBNP of 0.91 (0.86, 0.98). The association was only observable in women (0.80 [0.72, 0.90]) compared with men (0.98 [0.91, 1.07]). Among people with incident diabetes, NT-proBNP was positively associated with diabetes complications: overall, 1.31 (1.13, 1.53); microvascular complications, 1.20 (1.01, 1.43); and macrovascular complications, 1.37 (1.03, 1.83). CONCLUSIONS: Although higher NT-proBNP levels are associated with lower diabetes risk, NT-proBNP is a biomarker for vascular complications in people who develop diabetes independent of potential confounders. Thus, NT-proBNP might be informative to monitor risk for diabetes-related microvascular and macrovascular complications, which should be further explored in future prospective studies.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Birukov A, Eichelmann F, Kuxhaus O, et al. Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications. Diabetes Care. 2020. PMID: 32816995. doi:10.2337/dc20-0553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。